Trial intelligence / Profile preview

Screening and Decolonization of S. Aureus in Surgery Outpatients

NCT02182115Phase 4Completed

Sponsor
University of Minnesota
Start
Jul 2014
Primary completion
Aug 2016
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mupirocin, chlorhexidine in surgical site infection (SSI), sponsored by University of Minnesota. Started Jul 2014; status: completed.

02

Drugs

mupirocinchlorhexidine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT02182115.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02182115.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call